-
EP4292593
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4292593
| EP4292593 - PHARMACEUTICAL COMPOSITION FOR PREVENTING CYTOKINE STORM [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 17.11.2023 Database last updated on 31.08.2024 | |
| Former | The international publication has been made Status updated on 19.08.2022 | Most recent event Tooltip | 19.04.2024 | Change: Validation states | published on 22.05.2024 [2024/21] | 19.04.2024 | Change - extension states | published on 22.05.2024 [2024/21] | Applicant(s) | For all designated states Kinki University 3-4-1, Kowakae Higashi-Osaka-shi Osaka 577-8502 / JP | [2023/51] | Inventor(s) | 01 /
NISHIDA Shozo Higashiosaka City, Osaka 5778502 / JP | 02 /
TSUBAKI Masanobu Higashiosaka City, Osaka 5778502 / JP | 03 /
TAKEDA Tomoya Higashiosaka City, Osaka 5778502 / JP | 04 /
TANABE Genzoh Higashiosaka City, Osaka 5778502 / JP | 05 /
TAKASHIMA Katsuki Higashiosaka City, Osaka 5778502 / JP | 06 /
MORIKAWA Toshio Higashiosaka City, Osaka 5778502 / JP | [2023/51] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [2023/51] | Application number, filing date | 22752864.3 | 14.02.2022 | [2023/51] | WO2022JP05709 | Priority number, date | JP20210021955 | 15.02.2021 Original published format: JP 2021021955 | [2023/51] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022173042 | Date: | 18.08.2022 | Language: | JA | [2022/33] | Type: | A1 Application with search report | No.: | EP4292593 | Date: | 20.12.2023 | Language: | EN | [2023/51] | Search report(s) | International search report - published on: | JP | 18.08.2022 | Classification | IPC: | A61K31/352, A23L33/10, A61P37/02, A61P43/00 | [2023/51] | CPC: |
A23L33/10 (EP);
A61K31/7048 (US);
A61K31/352 (EP,US);
A61K9/0053 (US);
A61P37/06 (US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/51] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR VERHINDERUNG VON ZYTOKINSTURM | [2023/51] | English: | PHARMACEUTICAL COMPOSITION FOR PREVENTING CYTOKINE STORM | [2023/51] | French: | COMPOSITION PHARMACEUTIQUE DESTINÉE À PRÉVENIR UN ORAGE CYTOKINIQUE | [2023/51] | Entry into regional phase | 31.08.2023 | Translation filed | 31.08.2023 | National basic fee paid | 31.08.2023 | Search fee paid | 31.08.2023 | Designation fee(s) paid | 31.08.2023 | Examination fee paid | Examination procedure | 31.08.2023 | Examination requested [2023/51] | Fees paid | Renewal fee | 31.08.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2020130102 (UNIV KINKI [JP]) [X] 4, 5 * entire text, in particular, claim 5 *; | [X]WO2020162638 (UNIV KINKI [JP]) [X] 4, 5 * entire text, in particular, claim 5 *; | [Y] - Ji-Sun Shin, Young-Su Noh , Dong-Hyun Kim , Young-Wuk Cho , Kyung-Tae Lee, "Mangiferin isolated from the rhizome of Anemarrhena asphodeloides inhibits the LPS-induced nitric oxide and prostagladin E2 via the NF-κB inactivation in inflammatory macrophages.", Natural Product Sciences, (20080101), vol. 14, no. 3, pages 206 - 213, XP055958595 [Y] 1-3 * entire text * | [Y] - Qu Shihui; Wang Wenqing; Li Depeng; Li Shumin; Zhang Like; Fu Yunhe; Zhang Naisheng, "Mangiferin inhibits mastitis induced by LPS via suppressing NF-ĸB and NLRP3 signaling pathways", International Immunopharmacology, ELSEVIER, AMSTERDAM, NL, NL , (20161214), vol. 43, doi:10.1016/j.intimp.2016.11.036, ISSN 1567-5769, pages 85 - 90, XP029881743 [Y] 1-3 * entire text * DOI: http://dx.doi.org/10.1016/j.intimp.2016.11.036 | [Y] - Chowdhury Apu, Lu Jihong, Zhang Rumeng, Nabila Jahan, Gao Hang, Wan Zhikang, Adelusi Temitope Isaac, Yin Xiaoxing, Sun Ying, "Mangiferin ameliorates acetaminophen-induced hepatotoxicity through APAP-Cys and JNK modulation", Biomedicine & Pharmacotherapy, ELSEVIER, FR, FR , (20190901), vol. 117, doi:10.1016/j.biopha.2019.109097, ISSN 0753-3322, page 109097, XP055958598 [Y] 1-3 * entire text * DOI: http://dx.doi.org/10.1016/j.biopha.2019.109097 | [Y] - Satoshi Shuto, "4) Prodrugs", Molecular theory of organic pharmaceuticals, JP, Kyoto Hirokawa Shoten, (20120825), pages 169 - 171, ISBN 978-4-901789-81-3, XP009539019 [Y] 1-3 * entire text * [Y] 1-3 | [Y] - Wilz, S. W., "A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted. ", Cytokine & Growth Factor Reviews, Elsevier Ltd, GB, GB , (20200801), vol. 58, doi:10.1016/j.cytogfr.2020.06.008, ISSN 1359-6101, pages 49 - 50, XP055958605 [Y] 1 * entire text * DOI: http://dx.doi.org/10.1016/j.cytogfr.2020.06.008 | [Y] - Gu Tingxuan, Zhao Simin, Jin Guoguo, Song Mengqiu, Zhi Yafei, Zhao Ran, Ma Fayang, Zheng Yaqiu, Wang Keke, Liu Hui, Xin Mingxia, Han Wei, Li Xiang, Dong Christopher D., Liu Kangdong, Dong Zigang, "Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model", Frontiers in Immunology, (20210128), vol. 11, doi:10.3389/fimmu.2020.621441, XP055877307 [Y] 1 * entire text * DOI: http://dx.doi.org/10.3389/fimmu.2020.621441 | [Y] - Convertino Irma, Tuccori Marco, Ferraro Sara, Valdiserra Giulia, Cappello Emiliano, Focosi Daniele, Blandizzi Corrado, "Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients", Critical Care, (20201201), vol. 24, no. 1, doi:10.1186/s13054-020-03020-3, XP055879485 [Y] 1 * entire text * DOI: http://dx.doi.org/10.1186/s13054-020-03020-3 | by applicant | JP2012020953 | WO2016104436 | - HU LWU WCHAI XLUO JWU Q, Bioorg. Med. Chem. Lett, (20110000), vol. 21, pages 4013 - 4015 | - CAS, no. 3542-72-1 |